Rhode Island SB 2532: AN ACT RELATING TO INSURANCE -- PRESCRIPTION DRUG BENEFITS--PRESCRIPTION DRUG MARKETING (Regulates prescription drug marketing by manufacturers using strategies offering various discounts to disguise costs of high priced drugs versus lower costs alternatives and makes discounts available to individuals without health insurance. Eff. 1/1/19.)

Status: 05/31/2018 Committee recommends passage of Sub A (as of 2018-05-31)

State: Rhode Island · Session: 2018 · Bill: SB 2532

Subjects: Business & Professions, Food and Drugs, Prescription drugs

Sponsors: Calkin, Goldin, Miller, Raptakis, Satchell

View Rhode Island SB 2532 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.